Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the FoF Domestic median (128 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 01 Sep 2025 – 20 Aug 2026, limited by Mirae Asset Multi Factor Passive FOF. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Mirae Asset Multi Factor Passive FOF | Nifty 500 |
|---|---|---|
| 01 Sep 2025 | ₹100.00 | ₹100.00 |
| 30 Sep 2025 | ₹99.23 | ₹100.09 |
| 30 Oct 2025 | ₹104.04 | ₹104.97 |
| 28 Nov 2025 | ₹104.94 | ₹105.37 |
| 28 Dec 2025 | ₹103.81 | ₹104.70 |
| 26 Jan 2026 | ₹100.44 | ₹99.97 |
| 25 Feb 2026 | ₹105.74 | ₹103.04 |
| 26 Mar 2026 | ₹96.97 | ₹94.56 |
| 24 Apr 2026 | ₹103.12 | ₹99.37 |
| 24 May 2026 | ₹104.29 | ₹99.73 |
| 22 Jun 2026 | ₹106.55 | ₹102.41 |
| 22 Jul 2026 | ₹104.95 | ₹101.90 |
| 20 Aug 2026 | ₹106.86 | ₹103.52 |
| Metric | Mirae Asset · Regular · IDCW NAV ₹10.84 Very High risk ★★★☆☆ 1Y | Category median FoF Domestic · 128 funds |
|---|---|---|
| +6.86% | +5.71% | |
| — | +10.60% | |
| — | +7.04% | |
| — | +8.12% | |
| +6.86% | +8.44% | |
| +6.94% | — | |
| — | +9.37% | |
| — | +8.64% | |
| — | +8.30% | |
| Risk | ||
| 14.51% | 13.12% | |
| 0.03 | 0.40 | |
| 0.04 | 0.57 | |
| -12.54% | -18.33% | |
| Nifty 500 | — | |
| — | +0.09% | |
| — | 0.95 | |
| — | 92.9% | |
| — | 81.4% | |
| 0.65% | 0.58% | |
| ₹24.11Cr | ₹372.62Cr | |
| 0.05% | — | |
| None | — | |
| ₹99 | — | |
| ₹5.00K | — | |
| — | 13% | |
| Ritesh Patel · 1y | — | |
| 01 Sep 2025 | — | |
| — | — | |
| — | — | |
| 0.4% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.